Evidence map›Paper›PMID 30940316›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2019

Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017.

Simon Packer, Bruno Pichon, Stephen Thompson, Jane Neale, Jacquelyn Njoroge, Rachel M Kwiatkowska, Isabel Oliver, Maggie Telfer, Michel Doumith, Camillus Buunaaisie and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Clinical Features and Antibiotic Susceptibility ofJournal of clinical medicine · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Communications medicine · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Simon PackerField Epidemiology Service, Public Health England, Bristol, United Kingdom.
Bruno PichonAntimicrobial Resistance and Healthcare Associated Infections Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
Stephen ThompsonPublic health laboratory Bristol, Public Health England, Bristol, United Kingdom.
Jane NealeBristol Drugs Project, Bristol, United Kingdom.
Jacquelyn NjorogeBlood Borne Virus Section, HIV & STI Department, National Infection Service, Public Health England, London, United Kingdom.
Rachel M KwiatkowskaField Epidemiology Service, Public Health England, Bristol, United Kingdom.
Isabel OliverField Epidemiology Service, Public Health England, Bristol, United Kingdom.
Maggie TelferBristol Drugs Project, Bristol, United Kingdom.
Michel DoumithAntimicrobial Resistance and Healthcare Associated Infections Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
Camillus BuunaaisieUniversity of West England, Bristol, United Kingdom.
Ellen HeinsbroekBlood Borne Virus Section, HIV & STI Department, National Infection Service, Public Health England, London, United Kingdom.
Noreen Hopewell-KellyUniversity of West England, Bristol, United Kingdom.
Monica DesaiBlood Borne Virus Section, HIV & STI Department, National Infection Service, Public Health England, London, United Kingdom.
Vivian HopePublic Health Institute, Liverpool John Moores University, Liverpool, United Kingdom.
Owen Martin WilliamsPublic health laboratory Bristol, Public Health England, Bristol, United Kingdom.
Angela KearnsAuthors contributed equally to the work and share last authorship.
Mathew HickmanSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Maya GobinField Epidemiology Service, Public Health England, Bristol, United Kingdom.
Public Health England · GBAt Bristol · GBUniversity of the West of England · GBKing Saud bin Abdulaziz University for Health Sciences · SAUniversity of Bristol · GB

Funding

Medical Research Council MR/K023233/1Wellcome Trust
6 · The paper itself

Abstract

backgroundIn 2015, Bristol (South West England) experienced a large increase in cases of meticillin-resistant

aimWe aimed to characterise and estimate the prevalence of MRSA colonisation among PWID in Bristol and test evidence of a clonal outbreak.

methodsPWID recruited through an unlinked-anonymous community survey during 2016 completed behavioural questionnaires and were screened for MRSA. Univariable logistic regression examined associations with MRSA colonisation. Whole-genome sequencing used lineage-matched MRSA isolates, comparing PWID (screening and retrospective bacteraemia samples from 2012-2017) with non-PWID (Bristol screening) in Bristol and national reference laboratory database samples.

resultsThe MRSA colonisation prevalence was 8.7% (13/149) and was associated with frequently injecting in public places (odds ratio (OR): 5.5; 95% confidence interval (CI):1.34-22.70), recent healthcare contact (OR: 4.3; 95% CI: 1.34-13.80) and injecting in groups of three or more (OR: 15.8; 95% CI: 2.51-99.28). People reporting any one of: injecting in public places, injection site skin and soft tissue infection or hospital contact accounted for 12/13 MRSA positive cases (sensitivity 92.3%; specificity 51.5%). Phylogenetic analysis identified a dominant clade associated with infection and colonisation among PWID in Bristol belonging to ST5-SCCmecIVg.

conclusionsMRSA colonisation in Bristol PWID is substantially elevated compared with general population estimates and there is evidence of clonal expansion, community-based transmission and increased infection risk related to the colonising strain. Targeted interventions, including community screening and suppression therapy, education and basic infection control are needed to reduce MRSA infections in PWID.

Indexed as

AdultBacteremiaCommunity-Acquired InfectionsCross-Sectional StudiesFemaleHumansMaleMethicillin-Resistant Staphylococcus aureusMolecular EpidemiologyMolecular TypingPhylogenyPrevalenceRetrospective StudiesRisk FactorsStaphylococcal InfectionsSubstance Abuse, IntravenousCommunity acquired infectionsCommunity acquired infections epidemiologyCommunity acquired infections microbiologyDrug usersInjecting drug useIntravenousIntravenous: complicationsIntravenous: microbiologyMeticillin-Resistant Staphylococcus aureusMRSASepsisSequence Analysis, DNAStaphylococcal epidemiologyStaphylococcal Infections/transmissionSubstance AbuseSubstance-Related Disorders/complicationsSubstance-Related Disorders/microbiologyUnited KingdomWhole-genome sequencing

Identifiers

PMID30940316
PMCPMC6446509
OpenAlexW2931822510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.